Navigation Links
Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Date:9/6/2007

Temples Department of Emergency Medicine will participate in a nationwide study to pinpoint the best treatment for community-acquired MRSA, an increasingly common, antibiotic-resistant infection.

The objective of this trial is to determine the best outpatient therapy for otherwise healthy people who have MRSA, said David Karras, professor and associate chair of emergency medicine at the School of Medicine and Hospital, who will lead the research efforts at Temple.

There is no information on the optimal treatment for this latest strain, which is resistant to many of the traditional oral antibiotics.

As one of four subcontractors nationwide and the only site in Philadelphia, Temple will receive $1.8 million in funding from the Olive View-UCLA Education and Research Institute, the lead investigator for STOP MRSA*, a $9 million, five-year, five-center trial funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

STOP MRSA will evaluate various treatments for patients with skin and soft tissue infections caused by community-acquired-MRSA. Current treatments for MRSA include a variety of antibiotics and the draining of abscesses, but experts are not yet certain about the most effective treatment.

Karras also noted that another goal of the study is to gain approval from the Food and Drug Administration for the use of generic antibiotics to treat MRSA infections, which would offer patients a low-cost treatment option.

For decades, MRSA was considered an uncommon infection in healthy individuals, said Karras. But by 1996, otherwise healthy children and adults began to get MRSA infections for no apparent reason. Over the next six years, MRSA went from a rare community-associated disease to one of the most common forms of skin infection, he said, adding that many people carry the MRSA bacteria without developing an infection.

MRSA infections generally begin as a pimple before becoming an abscess, also called a boil. The skin often becomes red, tense and painful, a condition known as cellulitis. There may be pus drainage. Karras noted that patients often seek treatment for what they believe is a spider bite, only to find that they have an MRSA infection.

Patients can think that theyre suffering from insect bites, so they scratch and spread the bacteria to smaller cuts on other parts of their body without realizing it. They come to the emergency room with several welts, not realizing that the bumps are actually skin infections, Karras said.

In many urban areas, including Philadelphia, patients will visit the emergency room instead of a doctors office. For this reason, emergency medicine has been on the front lines of community-acquired MRSA prevention and treatment.

Close skin-to-skin contact, cuts or abrasions, contaminated items and surfaces, crowded living conditions and poor hygiene can promote the spread of MRSA. Experts advise the following precautions:

If a member of a household has an abscess, cellulitis or draining wound, he or she needs to see a doctor immediately. Additionally, linens should be segregated to protect uninfected members of the household.

For general hygiene and infection control, do not share personal items such as razors. Keep hands clean by washing thoroughly with soap and water or using an alcohol-based hand sanitizer. Keep cuts and scrapes clean and covered with a bandage until healed and avoid contact with other peoples wounds or bandages.

Temple has long been involved in Emergency ID Net, an 11-hospital network of emergency physicians studying emerging infectious diseases, said Karras. Originally, the group was formed as a surveillance unit. Interventional studies like STOP MRSA will help us determine the best treatment for our patients.

Other sites participating in this study are the Maricopa Medical Center in Phoenix, Ariz., Johns Hopkins University, and the Truman Medical Center at the University of Missouri-Kansas City.


'/>"/>

Contact: Renee Cree
renee.cree@temple.edu
215-707-1583
Temple University
Source:Eurekalert

Related medicine news :

1. Gas Masks Dont Always Fit an Emergency
2. London Emergency Services Receive Wide Appreciation
3. WHO declares Tuberculosis – ‘An Emergency’ in Afrca
4. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
5. Combination drugs for emergency heart attacks
6. Emergency Treatment Found Wanting In Anaphylactic Reactions
7. Men under 50 susceptible to suicide after discharge from emergency
8. Chlamydia Screening To Be Offered With Emergency Contraception
9. Lack of facilities in emergency rooms, warn Canadian nurses!
10. Apollo And Stanford Team To Train Emergency Medical Technicians
11. New Delhi to Host Conference on Accident & Emergency Medical Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
Breaking Medicine Technology: